Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CDC7 | O00311 | 2/20 | 0.41 |
| ▸ | DBF4 | Q9UBU7 | 2/20 | 0.41 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.41 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27224516 | 0.85 | KMT2A (0.46) | KMT2AKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL9721404 | 0.81 | ALDH1A1 (0.59) | KMT2AKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL21734206 | 0.81 | ALDH1A1 (0.59) | KMT2AKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL3933998 | 0.81 | KMT2A (0.50) | KMT2AKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL9721402 | 0.81 | ALDH1A1 (0.59) | KMT2AKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL3254725 | 0.81 | KMT2A (0.44) | KMT2AKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL3254726 | 0.81 | KMT2A (0.44) | KMT2AKDM4EALDH1A1MAPTMEN1 | |
| SCHEMBL30930824 | 0.80 | L3MBTL1 (0.52) | KMT2AALDH1A1MAPTMEN1SMN1; SMN2 | |
| SCHEMBL30930821 | 0.80 | L3MBTL1 (0.52) | KMT2AALDH1A1MAPTMEN1SMN1; SMN2 | |
| SCHEMBL22056211 | 0.80 | ESR1 (0.61) | KMT2AALDH1A1MAPTMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217932-A1 | PYRIDIUM ESTERS | THE PROCTER AND GAMBLE COMPANY | 2024-07-04 | — | — | US | disclosed |
| EP-4374698-A1 | PYRIDINIUM ESTERS | The Procter & Gamble Company (US) | 2024-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217932-A1 | PYRIDIUM ESTERS | C5, CBR3, CHRM1 | KMT2A 3425/4885KDM4E 1739/4885ALDH1A1 2024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.